Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech operating margin
Operating margin is operating income as a percentage of revenue.
Goldenwell Biotech's operating margin for the twelve months ending Jun 30, 2026 was -208729.1%. For fiscal 2025 it was -206047.3%, against -88559.7% the year before. The highest annual figure on record is -740.7% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -206047.3% | −117487.6 |
| FY2024 | Dec 31, 2024 | -88559.7% | −82251.1 |
| FY2023 | Dec 31, 2023 | -6308.6% | −4247.7 |
| FY2022 | Dec 31, 2022 | -2060.9% | −1320.2 |
| FY2021 | Dec 31, 2021 | -740.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -41627.3% | −31814.2 |
| Q2 FY2024 | Jun 30, 2024 | -34402.9% | −32039.6 |
| Q4 FY2023 | Dec 31, 2023 | -7999.6% | −7989.1 |
| Q3 FY2023 | Sep 30, 2023 | -9268.6% | −8546.8 |
| Q2 FY2023 | Jun 30, 2023 | -9813.0% | −1403.2 |
| Q1 FY2023 | Mar 31, 2023 | -2363.3% | −320.2 |
| Q3 FY2022 | Sep 30, 2022 | -10.5% | +718.7 |
| Q2 FY2022 | Jun 30, 2022 | -721.8% | – |
| Q1 FY2022 | Mar 31, 2022 | -8409.8% | – |
| Q4 FY2021 | Dec 31, 2021 | -2043.1% | – |
| Q3 FY2021 | Sep 30, 2021 | -729.2% | – |
See a number that looks wrong?